All stocks · Real Estate · Health Care REITs

Welltower WELL

Welltower scores average on business quality (5.1 of 10). Here is why, in plain words, and what our sealed record shows.

Last price$225.47Oct 9, 2026
Business qualityAverage
Next earningsOct 26, 2026
Insiders, 90 daysBuying

Why it matters

  1. What Welltower does

    Welltower Inc owns and operates healthcare real estate, collecting rent from senior housing operators, outpatient medical providers, and health systems. The firm benefits from demographic tailwinds as an aging population drives demand for specialized residential properties.

  2. What it does best

    Welltower dominates senior housing real estate through sheer scale and deep operating partner relationships, placing its revenue growth in the top decile of its sector at 35.6%. This asset footprint takes years to assemble, creating an effective barrier against new entrants.

  3. The main risk

    Interest coverage sits at a razor-thin 0.7x, meaning operating earnings fail to cover debt servicing costs. A spike in financing rates or a slip in rental income could instantly pressure the balance sheet and force dilutive capital raises.

Quality, check by check

Scored against its own industry, from company filings.

ProfitabilityWeak

Operating margins languish at 4.2% while gross margins hold near 40.3%, keeping profitability in the bottom quartile of its sector. Scale has not yet translated into efficient bottom-line conversion.

MoatWeak

The moat relies on specialized healthcare property scale and entrenched operator relationships, though low operating margin percentiles at 7% reflect limited structural pricing power. Rivals struggle to match its footprint quickly.

GrowthFast

Revenue surged to $12.8B, pushing revenue growth to 35.6% and ranking in the top decile of its sector. This top-line expansion accelerates well past historical levels, driven by aggressive senior housing acquisitions.

Financial healthWeak

With total debt at $19.7 billion against $5.0 billion in cash, interest coverage of 0.7x leaves little room for error. Free cash flow reached $1.6B, but heavy debt burdens mean the financial foundation remains under strain.

Insiders

Executives and directors, from SEC Form 4 filings we read ourselves. Open market trades only; grants, option exercises and pre-planned sales left out.

1 insider bought $2.4M on the open market.

Our sealed record on WELL

Verdicts appear here 30 days after we publish them; members see today's. Each one is in the nightly ledger, fingerprinted the night it was made.

The first sealed verdicts appear here on Oct 11, 2026.

Questions

Is WELL a good business?

Welltower scores average on the Cluenex quality check (5.1 of 10), measured against its own industry. Profitability is weak, moat weak, growth fast and financial health weak.

Are insiders buying WELL?

In the last 90 days of SEC Form 4 filings: 1 insider bought $2.4M on the open market.

When does WELL report earnings?

Oct 26, 2026.

For members

See WELL today

  • Today's verdict on WELL, and why
  • Fair value with cautious, base and optimistic cases
  • The exact price that would change the verdict
  • Which stocks each signal names, the night it fires
Open in Cluenex Free to start. First month of Core free.

Cite this page: Cluenex, “Welltower (WELL)”, https://cluenex.com/stocks/well/, data as of Oct 10, 2026.